OLC1, especially that localized in the nucleus, has a great chance to be a novel treatment target for gastric adenocarcinoma and even to help prevent gastric adenocarcinoma at the onset of tumor formation. This evidence concerns the gene IST1 and gastric adenocarcinoma.